This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fundacao Oswaldo Cruz-Fiocruz, Fundacao Oswaldo Cruz, Hoechst Aktiengesellschaft. Active years: 1993-2020.
Location History:
- Niterói, BR (2014)
- Rio De Janeiro, BR (1993 - 2020)
Company Filing History:
3 out of 32 
2 out of 28 
1 out of 6,705 
Years Active: 1993-2020
Title: Nubia Boechat: Innovator in Pharmaceutical Compounds
Introduction
Nubia Boechat is a prominent inventor based in Rio de Janeiro, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of serious diseases such as AIDS and tuberculosis. With a total of 6 patents, her work has the potential to impact public health positively.
Latest Patents
Nubia Boechat's latest patents include innovative isatin-derived compounds that are designed for the treatment of AIDS. These compounds consist of various isatin derivatives, which are effective in inhibiting HIV. The invention also addresses the treatment of infections caused by HBV or co-infection with HIV and HBV. Additionally, she has developed azole compounds that serve as tuberculostatic and leishmanicide agents. These new 1,2,3-triazole and imidazole compounds are included in a pharmaceutical composition aimed at treating tuberculosis and leishmaniasis.
Career Highlights
Throughout her career, Nubia has worked with esteemed institutions such as Fundação Oswaldo Cruz, commonly known as Fiocruz. Her research and innovations have garnered attention in the scientific community, contributing to advancements in medical treatments.
Collaborations
Nubia has collaborated with notable colleagues, including Marilia Dos Santos Costa and Ivan Neves, Jr. These partnerships have enhanced her research efforts and broadened the impact of her inventions.
Conclusion
Nubia Boechat's contributions to pharmaceutical innovations demonstrate her commitment to improving health outcomes through her inventions. Her work continues to inspire future research in the field.